The Verge
Vox Media, Inc.
(1,000+)
FREE – On Google Play
Quick read
Researchers at the University of Pennsylvania have been developing and testing a new cancer treatment that reprograms T-cells using a disabled form of HIV to fight leukemia. The New York Times tells the story of Emma Whitehead, a seven-year-old who is now in complete remission after receiving a T-cell transplant to combat the disease. So far, only twelve patients have received the experimental treatment, but four of them — including Emma — have made a full recovery as a result. For more on the new technique that some doctors say could be a "major breakthrough," check out the full article at the source link below.
There are 35 Comments. Load 'Em Up. Show speed reading tips and settings
Shortcuts to mastering the comment thread. Use wisely.
C - Next Comment
X - Mark as Read
R - Reply
Z - Mark Read & Next
Shift + C - Previous
Shift + A - Mark All Read
Comment Settings
Live comment alert: Hide it!
Comments for this post are closed.